For laboratory and research use only · not for human or veterinary consumption · 18+
FreePen Starter Kit with your first order — pen, cartridges, tips, wipes & BAC water · a $39 value, added automatically
Limitless Peptides
Cart
Home / Fat Loss & Metabolic / Semaglutide
SEMAGLUTIDE5 mg RUO

Semaglutide

The GLP-1 that started the wave — now labeled for kidney and liver disease too.

  • 94% homology to native GLP-1, acting on hypothalamic satiety
  • FLOW earned it a chronic kidney disease indication in 2025
  • Wegovy added MASH with F2–F3 fibrosis in August 2025
≥99% purity HPLC-tested Fat Loss & Metabolic Best seller
Size
$39per vial

Free shipping over $200 · $10 flat otherwise · ships cold from the USA

Full research summary5 citations

Semaglutide is the FDA-approved GLP-1 receptor agonist behind Ozempic and Wegovy, with 94% amino-acid homology to native GLP-1. It quiets hunger through hypothalamic satiety centres and slows gastric emptying. What keeps researchers watching is how fast the label is widening: chronic kidney disease in January 2025, MASH with F2-F3 fibrosis in August 2025.

  • FDA-approved GLP-1 receptor agonist with 94% amino-acid homology to native GLP-1, acting through hypothalamic satiety centres plus delayed gastric emptying.Peptide Guide p. 89
  • The FLOW trial earned it an FDA indication in chronic kidney disease in January 2025.FDA indications (FLOW, Jan 2025)
  • Wegovy added MASH with F2-F3 fibrosis in August 2025, on top of type-2 diabetes glycemic control and cardiovascular-risk reduction in established CVD.FDA indications (Aug 2025)
  • In published sex-difference research, women lose more weight than men at the same dose while reporting more GI effects.GLP-1 sex differences (PubMed)
  • In men, GLP-1 exposure raises total testosterone, SHBG and gonadotropins as weight drops, improves sperm and erectile function, and preserves fertility, unlike TRT.Jensterle 2020

Storage & handling

Freeze-dried at -4F; once reconstituted, 36-46F and best used within 28 days (sterility is the limiting factor, per the DailyMed pen label's in-use date: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=semaglutide).

Research cautions

Research use only. Label contraindications include personal or family history of medullary thyroid carcinoma or MEN 2 and any prior pancreatitis, and rare NAION (sudden, usually irreversible vision loss) was added to EU labels in 2025.

Storage & handling

Freeze-dried at -4F; once reconstituted, 36-46F and best used within 28 days (sterility is the limiting factor, per the DailyMed pen label's in-use date: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=semaglutide).

Research cautions

Research use only. Label contraindications include personal or family history of medullary thyroid carcinoma or MEN 2 and any prior pancreatitis, and rare NAION (sudden, usually irreversible vision loss) was added to EU labels in 2025.

Shipping & payment

$10 flat-rate shipping, free on orders over $200, shipped within the USA only. Submitting an order requests a manual invoice — nothing is charged on this site, and payment details arrive by email. If tracking confirms a lost shipment we reship once at no charge; orders are not refundable once shipped.

This compound is supplied for laboratory research use only and is not for human or veterinary consumption. The research summarized here describes published third-party findings, not outcomes from Limitless Peptides, and is not dosing guidance or medical advice.

More in Fat Loss & Metabolic

View all →